Henning Ulrich
Overview
Explore the profile of Henning Ulrich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
260
Citations
4408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Mello R, Bento C, de Oliveira Faria R, Arnaud-Sampaio V, Ulrich H, Miyagi M, et al.
Purinergic Signal
. 2025 Mar;
PMID: 40075009
Neuroblastoma is a pediatric tumor accounting for approximately 8% of childhood cancers and is associated with high mortality rates among children aged 1 to 5 years. Standard treatments often fall...
2.
3.
Carvalho G, Cavalcante D, Parreira R, Chiareli R, Ortiz Leoncini G, Gomez R, et al.
Neuroscience
. 2025 Jan;
568:116-129.
PMID: 39826672
L-proline is an amino acid with a unique cyclic structure, involvement in various physiological processes, such as protein synthesis, collagen production, and neurotransmission. This review explores the complex roles of...
4.
da Silva K, Lima I, Dos Santos C, Nonaka C, Souza B, David J, et al.
Molecules
. 2025 Jan;
30(1.
PMID: 39795214
Glioblastomas (GBM) are malignant tumours with poor prognosis. Treatment involves chemotherapy and/or radiotherapy; however, there is currently no standard treatment for recurrence, and prognosis remains unfavourable. Inflammatory mediators and microRNAs...
5.
Ferreira A, Ulrich H, Mori Y, Feng Z, Sun H, Britto L
Mol Neurobiol
. 2024 Nov;
62(4):5333-5346.
PMID: 39541072
Pharmacological inhibition of the transient receptor potential melastatin 2 (TRPM2), an oxidative stress-activated calcium channel, was previously reported to be protective in Parkinson's disease (PD). However, the inhibitors used were...
6.
Bento C, Arnaud-Sampaio V, Glaser T, Adinolfi E, Coutinho-Silva R, Ulrich H, et al.
Purinergic Signal
. 2024 Oct;
PMID: 39425818
Tumor-associated macrophages (TAMs) exhibit antitumor or protumor responses related to inflammatory (or M1) and alternative (or M2) phenotypes, respectively. The P2X7 receptor plays a key role in macrophage polarization, influencing...
7.
Cavalcante D, Nunes A, da Silva E, de Carvalho G, Chiareli R, Oliveira-Lima O, et al.
Exp Neurol
. 2024 Oct;
383:115006.
PMID: 39424040
Glycine Transporter Type 1 (GlyT1) inhibition confers neuroprotection against different forms of cerebral damage. This effect occurs through the elevation of synaptic glycine concentrations, which enhances N-methyl-d-aspartate receptor (NMDAR) activation...
8.
Ulrich H, Glaser T, Thomas A
Purinergic Signal
. 2024 Sep;
PMID: 39320433
Purinergic signaling regulates many metabolic functions and is implicated in liver physiology and pathophysiology. Liver functionality is modulated by ionotropic P2X and metabotropic P2Y receptors, specifically P2Y1, P2Y2, and P2Y6...
9.
Juvenal G, Higa G, Bonfim Marques L, Tessari Zampieri T, Viana F, Britto L, et al.
Purinergic Signal
. 2024 Jul;
PMID: 39046648
Purinergic receptors regulate the processing of neural information in the hippocampus and cerebral cortex, structures related to cognitive functions. These receptors are activated when astrocytic and neuronal populations release adenosine...
10.
Markus R, Sousa K, Ulrich H, Ferreira Z
Purinergic Signal
. 2024 Jul;
PMID: 39031242
In mammal's pineal glands, ATP interacts with the high-affinity P2Y and the low-affinity P2X7 receptors. ATP released from sympathetic nerve terminals potentiates noradrenaline-induced serotonin N-acetyltransferase (Snat) transcription, N-acetylserotonin (NAS), and...